BioSpace News Archive

Innovent Biologics, Inc. (“Innovent” or “the Company”) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today announced that the Company achieved first patient dosing in a pivotal Phase 2 registrational trial of pemigatinib (IBI375), a FGFR1/2/3 inhibitor, in China.

BlueRock Therapeutics, LP today announced the addition of Seth Ettenberg, Ph.D. to the company’s senior leadership team.

Amplity Health, one of the world’s leading pure-play pharmaceutical commercialization organizations with a reputation as a true partner for its clients, announced the election of Anthony C. Hooper, former Executive Vice President of Global Commercial Operations at Amgen, to its board of directors.

Fiscal Year 2020 Total Revenues of $1,104.1M, up 28% Year-over-year; Q4 Total Revenues of $311.5M, up 34% Year-over-year

Phase 2 interim data at three months, expected in 3Q 2020, intended to inform Phase 3 dose selection

TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offeringother estimated offering expenses. The Company sold 14,550,000 shares of common stock at $1.10 per share. Following the offering, the Company had an aggregate of 49,227,634 shares o

March 3, 2020 22:00 UTC LATTICE BIOLOGICS LTD. Transferred To TSX Venture Exchange Tier 2

Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, and Bristol-Myers Squibb Company (NYSE:BMY) today announced a collaboration agreement to create and investigate digital therapeutic solutions that will support cancer patients.

One-Touch Technology Enhances Remote Patient-Provider Interactions, Enables Practices to Position for COVID-19 Through Flu Season, Improves Access and Timeliness of Care [03-March-2020] ATLANTA , March 3, 2020 /PRNewswire/ -- Over the last week, the CDC and World Health Organization (WHO) have been responding to the outbreak of coronavirus (COVID-19) and the WHO has u